| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Akira Baba, Kimiichi Uno, Yumi Okuyama, Yohei Munetomo, Shintaro Nakajima, Kennosuke Mizushina, Hideto Kamed. Giant cell arteritis with polymyalgia rheumatica on FDG-PET/CT. Clinical case reports. vol 5. issue 7. 2020-09-30. PMID:28680624. |
if there is no pain in the temporal artery, the diagnosis of giant cell arteritis (gca) may be delayed and blindness may occur. |
2020-09-30 |
2023-08-13 |
Not clear |
| Thomas N Ward, Morris Levin, Robert L Won. Headache Caused by Giant Cell Arteritis. Current treatment options in neurology. vol 6. issue 6. 2020-09-29. PMID:15461927. |
however, the most serious complications of gca, blindness and stroke, may occur in the absence of headache. |
2020-09-29 |
2023-08-12 |
Not clear |
| Edsel B Ing, Royce Ing, Xinyang Liu, Angela Zhang, Nurhan Torun, Michael Sey, Christian Pagnou. Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study. Clinical ophthalmology (Auckland, N.Z.). vol 12. 2020-09-29. PMID:29391771. |
giant cell arteritis (gca) is the most common systemic vasculitis in the elderly and can cause irreversible blindness and aortitis. |
2020-09-29 |
2023-08-13 |
Not clear |
| E Wipfler-Freißmuth, C Dejaco, M Bot. [Long-term complications, monitoring and interventional treatment of large vessel vasculitis]. Zeitschrift fur Rheumatologie. vol 79. issue 6. 2020-09-11. PMID:32430565. |
the most frequent disease-associated complications include visual impairment up to blindness in gca, as well as vascular stenoses with ischemia and aortic aneurysms with possible dissection in gca and tak. |
2020-09-11 |
2023-08-13 |
Not clear |
| Thorsten Bley, Michael Zänker, Claudia Dechant, Nils Venhof. [Current Recommendations for Diagnostics in Giant Cell Arteritis]. Deutsche medizinische Wochenschrift (1946). vol 144. issue 9. 2019-08-27. PMID:31026867. |
in giant cell arteritis (gca), a timely diagnosis is required to avoid severe complications such as blindness or structural vascular damage. |
2019-08-27 |
2023-08-13 |
Not clear |
| Anouk Le Goueff, James Peters, Lisa Willcocks, David Jayn. Visual loss in giant cell arteritis 3 weeks after steroid initiation. BMJ case reports. vol 12. issue 3. 2019-06-24. PMID:30846454. |
giant cell arteritis (gca) is the most common vasculitis in adults and blindness is a common complication if left untreated. |
2019-06-24 |
2023-08-13 |
Not clear |
| Anouk Le Goueff, James Peters, Lisa Willcocks, David Jayn. Visual loss in giant cell arteritis 3 weeks after steroid initiation. BMJ case reports. vol 12. issue 3. 2019-06-24. PMID:30846454. |
we present the case of a 77-year-old man who developed irreversible bilateral blindness after a confirmed diagnosis of gca and oral steroid treatment. |
2019-06-24 |
2023-08-13 |
Not clear |
| Jem V Ninan, Susan Lester, Catherine L Hil. Diagnosis and management of giant cell arteritis: an Asia-Pacific perspective. International journal of rheumatic diseases. vol 22 Suppl 1. 2019-05-28. PMID:29667308. |
newer approaches such as fast-track pathways can also result in improvements in consequences of gca including blindness. |
2019-05-28 |
2023-08-13 |
Not clear |
| Dhruv K Modi, Khusbboo Sheth, Stefanie Wade, Rochelle Castillo, Sukrut Nanavaty, Syed Salman Al. Bilateral Giant Cell Arteritis Presenting as Bilateral Sudden Vision Loss. Connecticut medicine. vol 81. issue 4. 2018-05-22. PMID:29714410. |
ocular involvement frequently occurs in gca; if not promptly diagnosed, it can cause devastating ocular complications including complete vision loss and permanent blindness. |
2018-05-22 |
2023-08-13 |
Not clear |
| James A Prior, Hoda Ranjbar, John Belcher, Sarah L Mackie, Toby Helliwell, Jennifer Liddle, Christian D Malle. Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis. BMC medicine. vol 15. issue 1. 2017-11-16. PMID:28655311. |
giant cell arteritis (gca), if untreated, can lead to blindness and stroke. |
2017-11-16 |
2023-08-13 |
Not clear |
| Max Yates, Alex J MacGregor, Joanna Robson, Anthea Craven, Peter A Merkel, Raashid A Luqmani, Richard A Watt. The association of vascular risk factors with visual loss in giant cell arteritis. Rheumatology (Oxford, England). vol 56. issue 4. 2017-06-26. PMID:27940595. |
blindness is a recognized complication of gca; however, the frequency of and risk factors for this complication have not been firmly established. |
2017-06-26 |
2023-08-13 |
Not clear |
| Max Yates, Alex J MacGregor, Joanna Robson, Anthea Craven, Peter A Merkel, Raashid A Luqmani, Richard A Watt. The association of vascular risk factors with visual loss in giant cell arteritis. Rheumatology (Oxford, England). vol 56. issue 4. 2017-06-26. PMID:27940595. |
the aim of this study was to examine the incidence and determinants of blindness in patients with gca, using a large international cohort. |
2017-06-26 |
2023-08-13 |
Not clear |
| Ukamaka Nwadibia, Eric Larson, Joseph Fanciull. Polymyalgia Rheumatica and Giant Cell Arteritis: A Review Article. South Dakota medicine : the journal of the South Dakota State Medical Association. vol 69. issue 3. 2016-06-07. PMID:27156261. |
gca is the most common vasculitis in adults and affects medium and large arteries and can result in blindness if untreated. |
2016-06-07 |
2023-08-13 |
Not clear |
| Susan Lester, Alex W Hewitt, Carlee D Ruediger, Linda Bradbury, Elisabeth De Smit, Michael D Wiese, Rachel Black, Andrew Harrison, Graeme Jones, Geoffrey O Littlejohn, Tony R Merriman, Bain Shenstone, Malcolm D Smith, Maureen Rischmueller, Matthew A Brown, Catherine L Hil. PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis. RMD open. vol 2. issue 1. 2016-04-25. PMID:27110387. |
giant cell arteritis (gca) is one of the commonest forms of vasculitis in the elderly, and may result in blindness and stroke. |
2016-04-25 |
2023-08-13 |
Not clear |
| Hao Chen, Donghang Zheng, Sriram Ambadapadi, Jennifer Davids, Sally Ryden, Hazem Samy, Mee Bartee, Eric Sobel, Erbin Dai, Liying Liu, Colin Macaulay, Anthony Yachnis, Cornelia Weyand, Robert Thoburn, Alexandra Luca. Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis. PloS one. vol 10. issue 2. 2016-01-08. PMID:25658487. |
giant cell arteritis (gca) and takayasu's disease are inflammatory vasculitic syndromes (ivs) causing sudden blindness and widespread arterial obstruction and aneurysm formation. |
2016-01-08 |
2023-08-13 |
mouse |
| Cristina Ponte, Ana Filipa Rodrigues, Lorraine O'Neill, Raashid Ahmed Luqman. Giant cell arteritis: Current treatment and management. World journal of clinical cases. vol 3. issue 6. 2015-06-19. PMID:26090367. |
glucocorticoids remain the cornerstone of medical therapy in giant cell arteritis (gca) and should be started immediately to prevent severe consequences of the disease, such as blindness. |
2015-06-19 |
2023-08-13 |
Not clear |
| S Tsetsou, P Michel, C Ribi, L Hirt, A Kawasaki, O Hugli, L De Leval, P-A Bart, G Waeber, R Meuli, W Raffoul, A So, R Du Pasquie. [Giant cell arteritis: guidelines of the University Hospital of Lausanne]. Revue medicale suisse. vol 11. issue 461. 2015-06-18. PMID:25895220. |
yet, gca is an emergency and the treatment must be initiated very rapidly due to the risk of blindness. |
2015-06-18 |
2023-08-13 |
Not clear |
| Susan P Mollan, Noor Sharrack, Mike A Burdon, Alastair K Dennisto. Aspirin as adjunctive treatment for giant cell arteritis. The Cochrane database of systematic reviews. issue 8. 2014-09-19. PMID:25087045. |
giant cell arteritis (gca) is a common inflammatory condition that affects medium and large-sized arteries and can cause sudden, permanent blindness. |
2014-09-19 |
2023-08-13 |
Not clear |
| Wolfgang A Schmid. Role of ultrasound in the understanding and management of vasculitis. Therapeutic advances in musculoskeletal disease. vol 6. issue 2. 2014-06-24. PMID:24688604. |
fast-track clinics for the diagnosis of gca help to initiate treatment before complications such as blindness occur; patients receive appointments within 24 h in these clinics. |
2014-06-24 |
2023-08-12 |
Not clear |
| Edel Marie Quinn, David E Kearney, Justin Kelly, Catherine Keohane, Henry Paul Redmon. Temporal artery biopsy is not required in all cases of suspected giant cell arteritis. Annals of vascular surgery. vol 26. issue 5. 2012-10-04. PMID:22285348. |
temporal artery biopsy (tab) is performed during the diagnostic workup for giant cell arteritis (gca), a vasculitis with the potential to cause irreversible blindness or stroke. |
2012-10-04 |
2023-08-12 |
Not clear |